Visakhapatnam, December 16, 2025: Erba Transasia, a leading global diagnostics and medicaltechnology company and a strong proponent of the Make in India initiative, has been awarded theWinner – Large Enterprise at the CII MedTech Quality Excellence Awards 2025, powered by the AndhraPradesh MedTech Zone (AMTZ).The
In a landmark event commemorating the birth anniversary of Dr. APJ Abdul Kalam, the building of the upcoming Erba Global MedTech University was officially handed over by Dr. Jitendra Sharma, Managing Director & CEO of Andhra Pradesh MedTech Zone Limited (AMTZ), to Mr. Suresh Vazirani,
Visakhapatnam, September 15, 2025: In a landmark moment for India’s MedTech ecosystem, Dr. Ajay Sood, Principal Scientific Advisor to the Hon’ble Prime Minister of India Shri Narendra Modi, officially released the M.Tech and MBA curriculum of Erba Global MedTech University, Visakhapatnam.The ceremony was graced by
Erba Transasia Group, India’s leading InVitro Diagnostic company, is proud to announce a groundbreaking achievement: it has become the first company in India to receive the Bureau of Indian Standards (BIS) certificate for its fully automated range of clinical chemistry analyzers, including the XL 200/EM
In a ground-breaking achievement for India’s medical diagnostics sector, Erba Transasia proudly announces the commercial launch of the country’s first indigenously manufactured MonkeyPox PCR test kit. Validated by the Indian Council for Medical Research (ICMR), this kit today received emergency approval from Central Drugs Standard
Beta-thalassemia is a hereditary blood disorder characterized by reduced or absent synthesis of the beta chains of hemoglobin, leading to decreased production of functional hemoglobin. This condition affects millions of people worldwide, particularly those of Mediterranean, Middle Eastern, and Southeast Asian descent. While beta-thalassemia manifests
